{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:12:52Z","timestamp":1774325572219,"version":"3.50.1"},"reference-count":43,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023262","name":"Jon Moulton Charity Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000364","name":"Stroke Association","doi-asserted-by":"publisher","award":["Dr Lisa Tedesco Triccas- SA PDF 20\\100007"],"award-info":[{"award-number":["Dr Lisa Tedesco Triccas- SA PDF 20\\100007"]}],"id":[{"id":"10.13039\/501100000364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,1,13]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>There is currently insufficient high-quality evidence to make general recommendations about high-dose high-intensity upper-limb rehabilitation programmes. Here we describe a randomised controlled trial that will determine the efficacy of two forms of high-dose, high-intensity upper-limb rehabilitation provided in a rehabilitation unit setting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>Patients with moderate upper-limb impairment (n=105, at least 6 months after stroke) will be randomised to either (1) high-dose high-intensity conventional upper-limb rehabilitation, (2) high-dose high-intensity virtual reality-based upper-limb rehabilitation and (3) usual care (a waiting list control group). Groups 1 and 2 will receive a minimum of 45 hours of active time on task over 3 weeks. Outcome measures will be collected at (T1) baseline; (T2) immediately post intervention and (T3) 3 months after the intervention has finished. The primary outcome measure will be the Fugl-Meyer Upper Extremity Assessment at 3 months after the intervention. Secondary outcome measures will be clinical, kinematic and neurophysiological using transcranial magnetic stimulation and electroencephalography. Explanatory measures will include MRI-based markers for integrity of the corticospinal tract, dorsal column-medial lemniscal pathway, grey and white matter and lesion load. The aim is to detect a difference of 7.25 points on the Fugl-Meyer Upper Extremity Assessment between each treatment group and the waitlist control group, with a power of 0.9 and significance of 0.025 (to account for two primary analyses). Analysis of change in the primary and secondary outcome measures will be performed using mulitple regression analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>The study protocol (V.1) has been approved by the Wales Research Ethics Committee 2 Cardiff (Rec reference: 22\/WA\/0065) on 15 March 2022. All recruited participants will provide informed consent. Trial results will be disseminated through peer-reviewed publications, presentations at major stroke\/neurorehabilitation conferences and outreach to relevant stakeholder communities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05527262\">NCT05527262<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-095766","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T20:21:17Z","timestamp":1739910077000},"page":"e095766","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["High-dose high-intensity Queen Square upper-limb rehabilitation for people with chronic stroke (INTENSIVE): protocol for a single-centre, randomised controlled trial"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct05527262","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05527262","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9097-9352","authenticated-orcid":false,"given":"Lisa","family":"Tedesco Triccas","sequence":"first","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK"},{"name":"Faculty of Rehabilitation Sciences, REVAL Rehabilitation Research Center, Hasselt University, Hasselt, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Sporn","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Coll I Omana","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran","family":"Brander","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust National Hospital for Neurology and Neurosurgery, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Kelly","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust National Hospital for Neurology and Neurosurgery, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Bestmann","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Ward","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK"},{"name":"University College London Hospitals NHS Foundation Trust National Hospital for Neurology and Neurosurgery, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"2025101810203399000_15.2.e095766.1","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(24)00038-3"},{"key":"2025101810203399000_15.2.e095766.2","doi-asserted-by":"publisher","DOI":"10.1177\/1545968312440745"},{"key":"2025101810203399000_15.2.e095766.3","doi-asserted-by":"publisher","DOI":"10.1080\/096382899297459"},{"key":"2025101810203399000_15.2.e095766.4","doi-asserted-by":"publisher","DOI":"10.1177\/1545968319846120"},{"key":"2025101810203399000_15.2.e095766.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2014.10.022"},{"key":"2025101810203399000_15.2.e095766.6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-319954"},{"key":"2025101810203399000_15.2.e095766.7","doi-asserted-by":"publisher","DOI":"10.1177\/15459683211000730"},{"key":"2025101810203399000_15.2.e095766.8","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24734"},{"key":"2025101810203399000_15.2.e095766.9","doi-asserted-by":"publisher","DOI":"10.1177\/1747493017714176"},{"key":"2025101810203399000_15.2.e095766.10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/1545968319886477","article-title":"Standardized Measurement of Quality of Upper Limb Movement After Stroke: Consensus-Based Core Recommendations From the Second Stroke Recovery and Rehabilitation Roundtable","volume":"33","author":"Kwakkel","year":"2019","journal-title":"Neurorehabil Neural Repair"},{"key":"2025101810203399000_15.2.e095766.11","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.34"},{"key":"2025101810203399000_15.2.e095766.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2013.03.007"},{"key":"2025101810203399000_15.2.e095766.13","doi-asserted-by":"publisher","DOI":"10.1177\/1545968315624784"},{"key":"2025101810203399000_15.2.e095766.14","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/gps.5162","article-title":"Accuracy of the short-form Montreal Cognitive Assessment: Systematic review and validation","volume":"34","author":"McDicken","year":"2019","journal-title":"Int J Geriatr Psychiatry"},{"key":"2025101810203399000_15.2.e095766.15","doi-asserted-by":"crossref","first-page":"101594","DOI":"10.1016\/j.rehab.2021.101594","article-title":"Cognitive assessment scale for stroke patients (CASP): A multicentric validation study","volume":"65","author":"Benaim","year":"2022","journal-title":"Ann Phys Rehabil Med"},{"key":"2025101810203399000_15.2.e095766.16","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.24.1.58"},{"key":"2025101810203399000_15.2.e095766.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001394","article-title":"Comparing the validity of the Modified Modified Ashworth Scale (MMAS) and the Modified Tardieu Scale (MTS) in the assessment of wrist flexor spasticity in patients with stroke: protocol for a neurophysiological study","volume":"2","author":"Abolhasani","year":"2012","journal-title":"BMJ Open"},{"key":"2025101810203399000_15.2.e095766.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2012.10.011"},{"key":"2025101810203399000_15.2.e095766.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02741.x"},{"key":"2025101810203399000_15.2.e095766.20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-036481","article-title":"Pushing the limits of recovery in chronic stroke survivors: a descriptive qualitative study of users perceptions of the Queen Square Upper Limb Neurorehabilitation Programme","volume":"10","author":"Kelly","year":"2020","journal-title":"BMJ Open"},{"key":"2025101810203399000_15.2.e095766.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.330.7495.843"},{"key":"2025101810203399000_15.2.e095766.22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7155.362"},{"key":"2025101810203399000_15.2.e095766.23","unstructured":"Cochrane Collaboration and Training . Template for Intervention Description and Replication (TIDieR), 2022. Available: https:\/\/training.cochrane.org\/resource\/template-intervention-description-and-replication-tidier"},{"key":"2025101810203399000_15.2.e095766.24","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00123.2017"},{"key":"2025101810203399000_15.2.e095766.25","doi-asserted-by":"publisher","DOI":"10.1177\/1545968317732662"},{"key":"2025101810203399000_15.2.e095766.26","doi-asserted-by":"publisher","DOI":"10.1053\/apmr.2001.18668"},{"key":"2025101810203399000_15.2.e095766.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2005.03.017"},{"key":"2025101810203399000_15.2.e095766.28","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/63.10.1606"},{"key":"2025101810203399000_15.2.e095766.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x"},{"key":"2025101810203399000_15.2.e095766.30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/JCN.0000000000000145","article-title":"Psychometric evaluation of the Stroke Impact Scale 3.0","volume":"30","author":"Vellone","year":"2015","journal-title":"J Cardiovasc Nurs"},{"key":"2025101810203399000_15.2.e095766.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2702.2008.02333.x"},{"key":"2025101810203399000_15.2.e095766.32","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-014-0834-1"},{"key":"2025101810203399000_15.2.e095766.33","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1097\/HTR.0000000000000349","article-title":"Using Robotics to Quantify Impairments in Sensorimotor Ability, Visuospatial Attention, Working Memory, and Executive Function After Traumatic Brain Injury","volume":"33","author":"Logan","year":"2018","journal-title":"J Head Trauma Rehabil"},{"key":"2025101810203399000_15.2.e095766.34","doi-asserted-by":"publisher","DOI":"10.1177\/1545968317697034"},{"key":"2025101810203399000_15.2.e095766.35","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.016020"},{"key":"2025101810203399000_15.2.e095766.36","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24309"},{"key":"2025101810203399000_15.2.e095766.37","article-title":"Measurement of motor-evoked potential resting threshold and amplitude of proximal and distal arm muscles in healthy adults. A reliability study","volume":"5","author":"Tedesco Triccas","year":"2018","journal-title":"J Rehabil Assist Technol Eng"},{"key":"2025101810203399000_15.2.e095766.38","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.3.323"},{"key":"2025101810203399000_15.2.e095766.39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0013-4694(96)95088-9","article-title":"3D localization of surface 10-20 EEG electrodes on high resolution anatomical MR images","volume":"102","author":"Yoo","year":"1997","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"2025101810203399000_15.2.e095766.40","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.brs.2017.07.011","article-title":"The reliability of commonly used electrophysiology measures","volume":"10","author":"Brown","year":"2017","journal-title":"Brain Stimul"},{"key":"2025101810203399000_15.2.e095766.41","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/brain\/awv156","article-title":"Connectivity measures are robust biomarkers of cortical function and plasticity after stroke","volume":"138","author":"Wu","year":"2015","journal-title":"Brain (Bacau)"},{"key":"2025101810203399000_15.2.e095766.42","doi-asserted-by":"publisher","DOI":"10.1162\/imag_a_00203"},{"key":"2025101810203399000_15.2.e095766.43","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102639","article-title":"Lesion Quantification Toolkit: A MATLAB software tool for estimating grey matter damage and white matter disconnections in patients with focal brain lesions","volume":"30","author":"Griffis","year":"2021","journal-title":"Neuroimage Clin"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-095766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:20:45Z","timestamp":1760808045000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-095766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,18]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjopen-2024-095766"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-095766","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}